Multi Modality Tumor Tracking qEASL (MMTT qEASL)

Semi-automatic tumor quantification

This semi-automated 3D (Volumetric) tumor response assessment tool, based on EASL (European Association for the Study of the Liver) criteria incorporates functional information from contrast-enhanced scans.

tumor tracking qeasl thumbnail

Benefits

  • Multi Modality Tumor Tracking supports the creation of Quantitative EASL (qEASL) maps used to measure segmented volumes of interest (VOI) in heterogeneous lesions.
  • Data are presented as color map overlaid on the scans to show regional tumor enhancement heterogeneity. The color regions of the segmented lesions are where there is more enhancement than the pre-defined reference region.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

Olete sisenemas Philips HealthCare Eesti veebilehele.
Please select the checkbox

Veebilehel esitatud teave on mõeldud ainult isikutele, kes kasutavad meditsiiniseadmeid oma majandus- ja kutsetegevuses, sealhulgas tervishoiutöötajatele, tervishoiuteenuse osutajate esindajatele ning meditsiiniseadmetega oma majandus- ja kutsetegevuse raames kauplevatele isikutele. Veebilehel esitatud teave ei ole mõeldud meditsiiniliste nõuannete, ravijuhiste ega mistahes muude tervishoiualaste soovituste või suuniste andmiseks.

Kas olete isik, kes vastab ülaltoodud kriteeriumidele?